Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 28–28 | Cite as

Alemtuzumab/immunosuppressants/valganciclovir

Cytomegalovirus infections and leucopenia: 6 case reports
Case report
  • 28 Downloads

Reference

  1. Korneffel K, et al. Low dose valganciclovir as cytomegalovirus prophylaxis in post-renal transplant recipients induced with alemtuzumab: A single-center study. Transplant Immunology 56: 101226, Oct 2019. Available from: URL: http://doi.org/10.1016/j.trim.2019.101226 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations